In vivoevolution of resistance ofPseudomonas aeruginosastrains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure

Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC

(2014) Gabriel Cabot et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre study

(2014) A.-G. Venier et al.   JOURNAL OF HOSPITAL INFECTION

Role of Pseudomonas aeruginosa AmpR on  -lactam and non- -lactam transient cross-resistance upon pre-exposure to subinhibitory concentrations of antibiotics

(2014) H. Kumari et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime

(2013) P. Grohs et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

nfxB as a Novel Target for Analysis of Mutation Spectra in Pseudomonas aeruginosa

(2013) Mariela R. Monti et al.   PLoS One

Quantitative Contributions of Target Alteration and Decreased Drug Accumulation to Pseudomonas aeruginosa Fluoroquinolone Resistance

(2012) Sebastian Bruchmann et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pan-β-Lactam Resistance Development in Pseudomonas aeruginosa Clinical Strains: Molecular Mechanisms, Penicillin-Binding Protein Profiles, and Binding Affinities

(2012) Bartolomé Moyá et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?

(2012) P.N.A. Harris et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study

(2011) Gabriel Cabot et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Ciprofloxacin Concentration on the Frequency and Nature of Resistant Mutants Selected fromPseudomonas aeruginosa mutSandmutTHypermutators

(2011) Natalia R. Morero et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mechanisms DecreasingIn VitroSusceptibility to the LpxC Inhibitor CHIR-090 in the Gram-Negative Pathogen Pseudomonas aeruginosa

(2011) Ruth E. Caughlan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem

(2011) E. Riera et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy

(2010) Mickaël Riou et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Efflux Pump Contribution to Multidrug Resistance in Clinical Isolates ofPseudomonas aeruginosa

(2010) Tyree H Kiser et al.   PHARMACOTHERAPY

Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms

(2009) P. D. Lister et al.   CLINICAL MICROBIOLOGY REVIEWS

In vivo dynamics of carbapenem-resistant Pseudomonas aeruginosa selection after suboptimal dosing

(2009) Vincent H. Tam et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006

(2008) G. G. Zhanel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resistance and Virulence of Pseudomonas aeruginosa Clinical Strains Overproducing the MexCD-OprJ Efflux Pump

(2008) K. Jeannot et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY